BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

Latest News

Trogenix Emerges from Stealth with Precision Gene …

Trogenix Emerges from Stealth with Precision Gene Therapy Platform to Target Aggressive Cancers

Trogenix Ltd has launched its Odysseus platform, leveraging Synthetic Super-Enhancer (SSE) technology to advance precision viral immunotherapy for aggressive cancers. Read More

Novartis Expands Radiopharmaceutical Portfolio with $745M Deal …

Novartis Expands Radiopharmaceutical Portfolio with $745M Deal with Ratio Therapeutics

Novartis has struck a licensing agreement with Boston-based biotech Ratio Therapeutics, securing global rights to a promising cancer candidate targeting somatostatin receptor 2 (SSTR2). The … Read More

Medable Adds Generative AI to Simplify and …

Medable Adds Generative AI to Simplify and Speed Up Clinical Trials

Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical trial workflows. The new feature, … Read More

40,000 NHS Healthcare Workers to Get AI Tool That Cuts Admin Time by 80%

Immunai and Teva Collaborate to Advance Clinical Trials in Oncology and Immunology

Enveda Advances AI-Discovered, Nature-Derived Drug ENV-294 to Phase 1 Trials

Genesis Therapeutics Collaborates with NVIDIA and Secures Additional NVentures Funding to Accelerate AI-Driven Drug Discovery

Recursion Unveils OpenPhenom-S/16: A Foundation Model for Microscopy Data

Schrödinger and Novartis Forge Partnership to Scale Computational Drug Discovery

Read latest news ›››

Latest Insights

10 Notable Biotech Companies With Recent Major …

by Andrii Buvailo, PhD

10 Notable Biotech Companies With Recent Major VC Rounds

As the biotech sector recovers to pre-COVID investment levels, venture capital firms have become more selective in their funding choices. In 2024, private U.S. drug … Read More

Obesity R&D: The Making of a $100 …

by Daniel Chancellor

Obesity R&D: The Making of a $100 Billion Market

Obesity has emerged as a focal point for drug development in recent years, driven by its growing prevalence across many countries. The burden on global … Read More

Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads

by Roman Kasianov

What will be the key trends in AI innovation in the Pharmaceutical Industry in 2025?

by Marina Hickson

Cautious Optimism in 2024 for Healthcare M&A

by Merlin Piscitelli

AI Is Key to Democratizing Drug Discovery

by Andrey Doronichev

Key Trends in Aging Research: Where Are We Now?

by Andrii Buvailo, PhD

Global Pharma R&D Investments Surpass $276 Billion Annually, Exceeding Previous Estimates

by Roman Kasianov

The Promise of Chatbots in Clinical Trials

by Illia Petrov

Even 10 Minutes Matter in Cancer Research

by Andrii Buvailo, PhD

Read all insights ›››

From Our Partners

Read All ›››

AI Is Key to Democratizing Drug Discovery

Sponsored by OPTIC

AI Is Key to Democratizing Drug Discovery

AI Breaches the Barrier Towards Better CNS …

Sponsored by Lantern Pharma

AI Breaches the Barrier Towards Better CNS Drug Discovery

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Sponsored by MEDSIR

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

How to Discover a Preclinical Drug Candidate …

Sponsored by Syntekabio

How to Discover a Preclinical Drug Candidate in Two Years

Partner Events

View all events ›››

Global Clinical Trials Connect 2025

Global Clinical Trials Connect 2025

Event Date: May 28, 2025 - May 29, 2025

Location: United Kingdom (London)

Website: Link

22nd BioPharma Clinical Trials Nexus Conference

22nd BioPharma Clinical Trials Nexus Conference

Event Date: March 13, 2025 - March 14, 2025

Location: Switzerland (Basel)

Website: Link

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

BIOCHINA 2025

Event Date: March 13, 2025 - March 15, 2025

Location: China (Suzhou International Expo Center)

Website: Link

London Biotechnology Show 2025

London Biotechnology Show 2025

Event Date: June 18, 2025 - June 19, 2025

Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)

Website: Link

Case Studies

Read All ›››

How Astellas Pharma Achieves R&D Operational Excellence …

Sponsored by Science Exchange

How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

Cyclica's Chemical Probes for DCAF1

Sponsored by Cyclica

Cyclica's Chemical Probes for DCAF1

QUAISAR Computational Platform for Designing Targeted Protein …

Sponsored by Roivant Sciences

QUAISAR Computational Platform for Designing Targeted Protein Degraders

Busting the PoseBusters v3: AI Docking Software …

Sponsored by RECEPTOR.AI

Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy

Using End-to-End Wet Lab Automation Combined with …

Sponsored by Arctoris

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Powering Cancer Drug Discovery and Development Using …

Sponsored by Lantern Pharma

Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

Interviews

Read All ›››

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

[Interview] A Company on the Cutting Edge …

[Interview] A Company on the Cutting Edge of COVID-19 Vaccine Development

Navigating the Crossroads of AI and Oncology: …

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

This South Korean Company is at the …

This South Korean Company is at the Forefront of AI-driven Drug Discovery

Most Read

13 Publicly Traded Biotechs Utilizing AI-based Research …

13 Publicly Traded Biotechs Utilizing AI-based Research Platforms (+ 2 Upcoming Public Debuts)

10 Companies Applying AI for Biologics Discovery

10 Companies Applying AI for Biologics Discovery

14 Companies Using Quantum Theory To Accelerate …

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

AI Drug Discovery: Unleashing the Potential of …

AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning